RRM2 and breast carcinoma: Opposite trends were witnessed in the miR-4500 mimic + oe-RRM2 group when compared with the oe-RRM2 group (p < 0.05), all of which suggested that overexpression of miR-4500 promoted breast cancer cell apoptosis through downregulation of RRM2.